🚨近一半服用伊维菌素 + 甲苯咪唑的癌症患者报告称，在6个月后癌症消失或肿瘤消退

84.4% 患者体验到临床获益
32.8% 患者报告无疾病证据
15.6% 患者报告肿瘤消退
36.1% 患者报告疾病稳定

我们的研究代表了迄今为止支持抗寄生虫疗法在癌症治疗中应用的最大且最具说服力的临床信号。

@McCulloughFund

@twc_health

@P_McCulloughMD

@DrHarveyRisch

@DrKellyVictory

@jathorpmfm

@drdrew

@PeterGillooly

@FosterCoulson

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS

84.4% EXPERIENCED CLINICAL BENEFIT
32.8% REPORTED NO EVIDENCE OF DISEASE
15.6% REPORTED TUMOR REGRESSION
36.1% REPORTED STABLE DISEASE

Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer.

@McCulloughFund

@twc_health

@P_McCulloughMD

@DrHarveyRisch

@DrKellyVictory

@jathorpmfm

@drdrew

@PeterGillooly

@FosterCoulson @NicHulscher http://t.cn/AXM5AgjC